BREAST FEEDING;
CASE CONTROL STUDY;
CENTRAL NERVOUS SYSTEM DEPRESSION;
CHILD DEATH;
DOSE RESPONSE;
DRUG DISPOSITION;
DRUG METABOLISM;
DRUG MILK LEVEL;
GENOTYPE;
HUMAN;
INDIVIDUALIZATION;
MATERNAL TREATMENT;
NEUROTOXICITY;
NOTE;
PAIN;
PERINATAL DRUG EXPOSURE;
PHARMACODYNAMICS;
PHARMACOGENETICS;
PHENOTYPE;
PREMATURITY;
PRIORITY JOURNAL;
PROBABILITY;
SIDE EFFECT;
SOMNOLENCE;
Pharmacogenetics of neonatal opioid toxicity following maternal use of codeine during breastfeeding: A case-control study
Madadi, P. et al. Pharmacogenetics of neonatal opioid toxicity following maternal use of codeine during breastfeeding: a case-control study. Clin. Pharmacol. Ther. 85, 31-35 (2009).
Breastfeeding in the United States: Findings from the National Health and Nutrition Examination Surveys 1999-2006
National Center for Health Statistics, Hyattsville, MD
McDowell, M.A., Wang, C-Y. & Kennedy Stephenson, J. Breastfeeding in the United States: Findings from the National Health and Nutrition Examination Surveys 1999-2006. NCHS data briefs, no. 5 (National Center for Health Statistics, Hyattsville, MD, 2008).
US Department of Health and Human Services, Washington, DC
US Department of Health and Human Services. Healthy People 2010 (US Department of Health and Human Services, Washington, DC, 2000) 〈http://www.healthypeople.gov/Document/html/uih/uih_2.htm#obj〉.